Articles > Popular publications > PR Newswire press releases > July-September 1990 > Friday, September 7

Article: Synergen begins clinical trials in rheumatoid arthritis patients.

Article from:
PR Newswire
Article date:
September 7, 1990
Copyright

SYNERGEN BEGINS CLINICAL TRIALS IN RHEUMATOID ARTHRITIS PATIENTS

BOULDER, Colo., Sept. 7 /PRNewswire/ -- Synergen Inc. (NASDAQ: SYGN) announced that testing of its anti-inflammatory agent, Interleukin-1 receptor antagonist (IL-1ra), began this week in patients with rheumatoid arthritis.

The initial clinical trials will focus on safety and appropriate dosing levels. Subsequent trials at medical centers across the United States will study IL-1ra's effectiveness in reducing the pain and joint destruction associated with advanced rheumatoid arthritis.

In laboratory tests, administration of IL-1ra in animal models of rheumatoid arthritis has ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Regeneron Announces Encouraging Initial Results in Phase I Study ...
Business Wire;  November 14, 2001 ;     700+ words ... ... safety and tolerability of IL-1 Trap in patients with rheumatoid arthritis. Based on these results ... Interleukin 4/13 Dual Trap." Rheumatoid Arthritis, IL-1, and Regeneron's IL-1 Cytokine Trap Rheumatoid arthritis is a chronic disease in ...

Article: Interleukin Genetics and ScHARR Economic Modeling Study ...
Business Wire;  October 28, 2002 ;     700+ words ... ... the cytokines IL-1 and TNF alpha in rheumatoid arthritis disease activity ... agents to treat rheumatoid arthritis both with and ... of patients' IL-1 gene variations ... response to anti-IL-1 and anti-TNFa rheumatoid arthritis therapies and ...

Article: Anti-IL-6/R Antagonists: new players in the ...
M2 Presswire;  February 16, 2009 ;     700+ words ... ... Markets: Anti-IL-6/R Antagonists ... players in the rheumatoid arthritis market(C ... Receptor (IL-6R) Antagonists ... treatment of rheumatoid arthritis and multiple ... Apart from rheumatoid arthritis, the potential of anti-IL-6/R agents ...

Article: Synta Pharmaceuticals Initiates Phase 2 Clinical Trials in ...
PR Newswire;  May 24, 2006 ;     700+ words ... ... STA-5326), in rheumatoid arthritis (RA) and common variable ... the production of the IL-12 protein family ... including IL-12 and IL-23) is the master ... disease, psoriasis, rheumatoid arthritis, multiple sclerosis ... over-production of IL-12 and IL-23, and ...

Article: Anti-IL-6/R Antagonists: New Players in the ...
Blood Weekly;  March 5, 2009 ;     647 words ... ... about Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists for treatment of rheumatoid arthritis and multiple myeloma provides ... towards phase I. Apart from rheumatoid arthritis, the potential of anti-IL-6/R agents is also being ...

Article: Chugai Announces Japanese Phase III Trial Data Demonstrates ...
JCN Newswires;  April 26, 2006 ;     700+ words ... ... phase III trials in rheumatoid arthritis are going on in 41 countries ... Reference Interleukin-6 (IL-6) IL-6 was identified ... inflammatory reactions. IL-6 also relates to ... inflammatory diseases, such as rheumatoid arthritis, Castleman's disease ... humanized anti-human ...

Article: Research and Markets: Anti-IL-6/R Antagonists: New Players ...
Business Wire;  February 16, 2009 ;     700+ words ... ... about Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists for treatment of rheumatoid arthritis and multiple myeloma provides ... towards phase I. Apart from rheumatoid arthritis, the potential of anti-IL-6/R agents is also being ...

Article: Regeneron Reports Phase II Results for IL-1 Trap Clinical ...
Business Wire;  October 7, 2003 ;     700+ words ... ... the Company's IL-1 Trap demonstrated ... patients with rheumatoid arthritis (RA) in a Phase ... activity of the IL-1 Trap in rheumatoid arthritis. Moreover, it ... forward for the IL-1 Trap in rheumatoid arthritis. Furthermore ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives